Helicobacter pylori antibiotic resistance patterns and genotypes in adult dyspeptic patients from a regional population in North Wales

Journal of Antimicrobial Chemotherapy

Volumn 54, Issue 2, 2004, Pages 435-440

  Elviss, Nicola C ^a   Owen, Robert J ^a   Xerry, Jacqueline ^a   Walker, A Mark ^b   Davies, Kenneth ^b  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b PUBLIC HEALTH WALES   (United Kingdom)

Author keywords

Clarithromycin; Dual resistance; Metronidazole; Surveillance

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CAGA PROTEIN; CLARITHROMYCIN; METRONIDAZOLE; TETRACYCLINE; VACUOLATING TOXIN;

ADOLESCENT; ADULT; AGAR GEL DIFFUSION; AGED; ALLELE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CONTROLLED STUDY; DYSPEPSIA; ERADICATION THERAPY; EUROPE; FEMALE; GENETIC VARIABILITY; GENOTYPE; HEALTH SURVEY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; TEST STRIP; UNITED KINGDOM;

ADULT; AGE FACTORS; ALLELES; DRUG RESISTANCE; DYSPEPSIA; FEMALE; GENES, BACTERIAL; GENOTYPE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; SEX FACTORS; WALES;

EID: 4444348018     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkh343     Document Type: Article

References (28)

1. Vyse, A. J., Gay, N. J., Hesketh, L. M. et al. (2002). The burden of Helicobacter pylori infection in England and Wales. Epidemiology and Infection 128, 411-7.
2. Suerbaum, S. & Michetti, P. (2002). Helicobacter pylori infection. New England Journal of Medicine 347, 1175-86.
3. Harris, A. & Misiewicz, J. J. (2001). ABC of the upper gastrointestinal tract. Management of Helicobacter pylori infection. British Medical Journal 323, 1047-50.
4. Malfertheiner, P., Mégraud, F., O'Morain, C. et al. (2002). Current concepts in the management of Helicobacter pylori infection - the Maastricht 2-2000 Consensus Report. Alimentary Pharmacology and Therapeutics 16, 167-80.
5. Mégraud, F. (2001). Resistance of Helicobacter pylori to antibiotics and its impact on treatment options. Drug Resistance Updates 4, 178-86.
6. Dore, M. P., Leandro, G., Realdi, G. et al. (2000). Effect of pretreatment antibiotic resistance to metronidazole and clarithromycin on outcome of Helicobacter pylori therapy: a meta-analytical approach. Digestive Diseases and Sciences 45, 68-76.
7. Mégraud, F., Lehn, N., Lind, T. et al. (1999). Antimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial: the MACH 2 study. Antimicrobial Agents and Chemotherapy 43, 2747-52.
8. Glupczynski, Y., Mégraud, F., Lopez-Brea, M. et al. (2001). European multicentre survey of in vitro antimicrobial resistance in Helicobacter pylori. European Journal of Clinical Microbiology and Infectious Diseases 20, 820-3.
9. Banatvala, N., Davies, G. R., Abdi, Y. et al. (1994). High prevalence of Helicobacter pylori metronidazole resistance in migrants to east London: relation with previous nitroimidazole exposure and gastroduodenal disease. Gut 35, 1562-6.
10. Parsons, H. K., Carter, M. J., Sanders, D. S. et al. (2001). Helicobacter pylori antimicrobial resistance in the United Kingdom: the effect of age, sex and socio-economic status. Alimentary Pharmacology and Therapeutics 15, 1473-8.
11. Teare, L., Peters, T., Saverymuttu, S. et al. (1999). Antibiotic resistance in Helicobacter pylori. Lancet 353, 241-2.
12. van Doorn, L. J., Schneeberger, P. M., Nouhan, N. et al. (2000). Importance of Helicobacter pylori cagA and vacA status for the efficacy of antibiotic treatment. Gut 46, 321-6.
13. Rubenstein, G., Dunkin, K. & Howard, A. J. (1994). The susceptibility of Helicobacter pylori to 12 antimicrobial agents, omeprazole and bismuth salts. Journal of Antimicrobial Chemotherapy 34, 409-13.
14. Andrews, J. (2003). BSAC Disc Diffusion Method for Antimicrobial Susceptibility Testing, Version 2.1.4. British Society for Antimicrobial Chemotherapy, Birmingham, UK.
15. National Committee for Clinical Laboratory Standards. (1999). Performance Standards for Antimicrobial Susceptibility Testing. Approved Standard M7-A5: Informational Supplement M100-S10. NCCLS, Wayne, PA, USA.
16. McNulty, C., Owen, R., Tompkins, D. et al. (2002). Helicobacter pylori susceptibility testing by disc diffusion. Journal of Antimicrobial Chemotherapy 49, 601-9.
17. King, A. (2001). Recommendations for susceptiblity tests on fastidious organisms and those requiring special handling. Journal of Antimicrobial Chemotherapy 48, Suppl. S1, 77-80.
18. Owen, R. J., Xerry, J., Peters, T. M. et al. (2002). Surveillance and clinical relevance of vacA genotypes of Helicobacter pylon infecting dyspeptic patients in mid-Essex. Communicable Disease and Public Health 5, 106-11.
19. Chisholm, S. A., Teare, E. L., Patel, B. et al. (2002). Determination of Helicobacter pylori vacA allelic types by single-step multiplex PCR. Letters in Applied Microbiology 35, 42-6.
20. Megraud, F. (2001). Resistance of Helicobacter pylori to antibiotics and its impact on treatment options. Drug Resistance Updates 4, 178-86.
21. van der Wouden, E. J., van Zwet, A. A., Thijs, J. C. et al. (1997). Rapid increase in the prevalence of metronidazole-resistant Helicobacter pylori in the Netherlands. Emerging Infectious Diseases 93, 1228-31.
22. Heep, M., Kist, M., Strobel, S. et al. (2000). Secondary resistance among 554 isolates of Helicobacter pylori after failure of therapy. European Journal of Clinical Microbiology and Infectious Diseases 19, 538-41.
23. Owen, R. J. (2002). Molecular testing for antibiotic resistance in Helicobacter pylori. Gut 50, 285-9.
24. Chisholm, S. A. & Owen, R. J. (2003). Mutations in Helicobacter pylori rdxA gene sequences may not contribute to metronidazole resistance. Journal of Antimicrobial Chemotherapy 51, 995-9.
25. Höcker, M. & Hohenberger, P. (2003). Helicobacter pylori virulence factors - one part of a big picture. Lancet 362, 1231-3.
26. Alm, R. A., Ling, L. S., Moir, D. T. et al. (1999). Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori. Nature 397, 176-80.
27. National Institute for Clinical Excellence. (2003). Dyspepsia: Managing Adult Patients in Primary Care. National Guideline Research and Development Unit. Second draft published 12 December 03. www.nice.org.uk.
28. Jenks, P. J., Labigne, A. & Ferrero, R. L. (1999). Exposure to metronidazole in vivo readily induces resistance in Helicobacter pylon and reduces the efficacy of eradication therapy in mice. Antimicrobial Agents and Chemotherapy 43, 777-81.